Bortezomib is active in patients with untreated or relapsed Waldenstrom's macroglobulinemia: a phase II study of the National Cancer Institute of Canada Clinical Trials Group
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Edward A. Stadtmauer National Cancer Institute of Canada Clinical Trials Group |
| Publication date | March 12, 2007 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |